These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 32526339

  • 1. Lei-gong-gen formula granule attenuates hyperlipidemia in rats via cGMP-PKG signaling pathway.
    Lan T, Li Q, Chang M, Yin C, Zhu D, Wu Z, Li X, Zhang W, Yue B, Shi J, Yuan H, Su Z, Guo H.
    J Ethnopharmacol; 2020 Oct 05; 260():112989. PubMed ID: 32526339
    [Abstract] [Full Text] [Related]

  • 2. A network pharmacology-based approach to explore the active ingredients and molecular mechanism of Lei-gong-gen formula granule on a spontaneously hypertensive rat model.
    Li Q, Lan T, He S, Chen W, Li X, Zhang W, Liu Y, Zhang Q, Chen X, Han Y, Su Z, Zhu D, Guo H.
    Chin Med; 2021 Oct 09; 16(1):99. PubMed ID: 34627325
    [Abstract] [Full Text] [Related]

  • 3. Antihyperlipidemic effect of Vaccinium dunalianum buds based on biological activity screening and LC-MS.
    Yang JH, Bai TC, Shi LL, Hou B, Tang R, Zhang RP, Chen XL.
    J Ethnopharmacol; 2023 Apr 24; 306():116190. PubMed ID: 36693548
    [Abstract] [Full Text] [Related]

  • 4. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y, Li X, Li X, Ju J, Liang H, Hu X, Dong L, Wang N, Li J, Zhang Y, Yang B.
    Biomed Pharmacother; 2019 Sep 24; 117():109176. PubMed ID: 31387185
    [Abstract] [Full Text] [Related]

  • 5. Screening of hypolipidemic active components in Jiang-Zhi-Ning and its preliminary mechanism research based on "active contribution value" study.
    Zhang Y, Li L, Zhang J, Lin T, Jiang Y, Liu B.
    J Ethnopharmacol; 2021 May 23; 272():113926. PubMed ID: 33596472
    [Abstract] [Full Text] [Related]

  • 6. Investigation of the Lipid-Lowering Mechanisms and Active Ingredients of Danhe Granule on Hyperlipidemia Based on Systems Pharmacology.
    Chen K, Ma Z, Yan X, Liu J, Xu W, Li Y, Dai Y, Zhang Y, Xiao H.
    Front Pharmacol; 2020 May 23; 11():528. PubMed ID: 32435189
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H, Tan H, Zhan W, Song L, Zhang D, Chen X, Lin Z, Wang W, Yang Y, Wang L, Bei W, Guo J.
    J Ethnopharmacol; 2021 Jun 28; 274():114056. PubMed ID: 33771638
    [Abstract] [Full Text] [Related]

  • 8. Effects of Danhong injection on dyslipidemia and cholesterol metabolism in high-fat diets fed rats.
    Du H, Li C, Wang Z, He Y, Wang Y, Zhou H, Wan H, Yang J.
    J Ethnopharmacol; 2021 Jun 28; 274():114058. PubMed ID: 33766756
    [Abstract] [Full Text] [Related]

  • 9. Hypolipidemic effect of Fragarianilgerrensis Schlecht. medicine compound on hyperlipidemic rats.
    Gao L, Lin Z, Liu Y, Wang X, Wan L, Zhang L, Liu X.
    Lipids Health Dis; 2018 Sep 19; 17(1):222. PubMed ID: 30231880
    [Abstract] [Full Text] [Related]

  • 10. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
    Leng X, Jia LQ, Yang GL, Wang JY, Zhu ML, Wang Y, Xu Y.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar 19; 35(3):320-6. PubMed ID: 25951638
    [Abstract] [Full Text] [Related]

  • 11. Antihyperlipidemic effect of Cyclocarya paliurus (Batal.) Iljinskaja extract and inhibition of apolipoprotein B48 overproduction in hyperlipidemic mice.
    Ma Y, Jiang C, Yao N, Li Y, Wang Q, Fang S, Shang X, Zhao M, Che C, Ni Y, Zhang J, Yin Z.
    J Ethnopharmacol; 2015 May 26; 166():286-96. PubMed ID: 25794806
    [Abstract] [Full Text] [Related]

  • 12. Lipid-lowering effects of Danhong injection on hyperlipidemia rats.
    Chen J, Deng J, Zhang Y, Yang J, He Y, Fu W, Xing P, Wan Ht.
    J Ethnopharmacol; 2014 Jun 11; 154(2):437-42. PubMed ID: 24751362
    [Abstract] [Full Text] [Related]

  • 13. Selection and evaluation of quality markers from Yinlan capsule and its LXRα-mediated therapy for hyperlipidemia.
    Chen Z, Sun D, Bi X, Luo W, Xu A, Chen W, Jiang J, Cai D, Guo H, Cao L.
    Phytomedicine; 2019 Jun 11; 59():152896. PubMed ID: 30978649
    [Abstract] [Full Text] [Related]

  • 14. Serum metabonomics coupled with HPLC-LTQ/orbitrap MS and multivariate data analysis on the ameliorative effects of Bidens bipinnata L. in hyperlipidemic rats.
    Wang YQ, Li SJ, Man YH, Zhuang G.
    J Ethnopharmacol; 2020 Nov 15; 262():113196. PubMed ID: 32730873
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of the polyphenol-rich extract from Allium cepa on hyperlipidemic sprague-dawley rats.
    Li W, Yang C, Mei X, Huang R, Zhang S, Tang Y, Dong Q, Zhou C.
    J Food Biochem; 2021 Jan 15; 45(1):e13565. PubMed ID: 33219537
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Lipid-lowering effect and mechanism of Danhong Injection on hyperlipidemia rats based on lipid metabolism disorder].
    DU HX, Zhou HF, He Y, Wan HT, Yang JH.
    Zhongguo Zhong Yao Za Zhi; 2020 Jul 15; 45(13):3203-3210. PubMed ID: 32726030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.